Publications & Presentations
Learn more about the work that we do in the Mateen Lab through our recent publications. For all publications, visit PubMed.
-
Rice DR, Doré M, Mara O, Enkhtsetseg N, Gebczak C, Cissé FA, Mateen FJ. Traditional Healers and Multiple Sclerosis in the Republic of Guinea: Implications for Referral Pathways, Early Diagnosis, and Health System Integration. Poster session presented at: MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Global Meeting; 2026 Oct 21-23; Toronto, Canada.
-
Lee S, Scheu R, Enkhtsetseg N, Hill J, Sadok J, Mastick M, Satish S, Mateen FJ. Risk of Infection in Ocrelizumab-Treated Adults with Multiple Sclerosis Aged 55 years and Older: A Retrospective Cohort Study. Poster session presented at: MSToronto 2026 - 10th Joint ACTRIMS-ECTRIMS Global Meeting; 2026 Oct 21-23; Toronto, Canada.
-
Chang AY, Mateen FJ. Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review. Ann Clin Transl Neurol. 2026 Oct 12:10.1002/acn3.70547. doi: 10.1002/acn3.70547. Epub ahead of print. PMID: 42860897.
-
Lee NJ, Beu AM, Amezcua L, Mateen FJ. Multiple sclerosis and housing insecurity or forcible displacement: A scoping review. Mult Scler. 2026 Oct 8:13524585261492505. doi: 10.1177/13524585261492505. Epub ahead of print. PMID: 42847437.
-
Rice DR, Doré M, Mara O, Enkhtsetseg N, Gebczak C, Cissé FA, Mateen FJ. Traditional healers' knowledge, experience, and practices related to multiple sclerosis in the Republic of Guinea: A mixed methods study. Mult Scler Relat Disord. 2026 Oct;114:107450. doi: 10.1016/j.msard.2026.107450. Epub 2026 Aug 14. PMID: 42623730.
-
Lee S, Scheu R, Enkhtsetseg N, Hill J, Sadok J, Mastick M, Satish S, Mateen FJ. Risk of infection in ocrelizumab-treated adults with multiple sclerosis aged 55 years and older: a retrospective cohort study. Lancet Reg Health Am. 2026 Sep 24;64:101640. doi: 10.1016/j.lana.2026.101640. PMID: 42834886.
-
Linnet T, Dixit K, Shah S. Gyriform Susceptibility Rim in Early Progressive Multifocal Leukoencephalopathy. Ann Neurol. 2026 Sep 12. doi: 10.1002/ana.78368. Epub ahead of print. PMID: 42730719.
-
Linnet T, Maas MB, Mateen FJ, Shah S. Detection of Aquaporin-4 antibody in cerebrospinal fluid in neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2026 Sep;113:107352. doi: 10.1016/j.msard.2026.107352. Epub 2026 Jun 27. PMID: 42401155.
-
Linnet T, Mateen FJ, Shah S. Clinical Utility of Cerebrospinal Fluid MOG-IgG Testing in Patients with Paired Serum and CSF Testing. Poster session presented at: 2026 AAN Autoimmune Neurology Conference; 2026 Aug 7-8; Houston, TX.
-
Mastick ML, Soumah CO, Doré M, Mara O, Neldje D, Cissé FA, Lamine TM, Diallo A, Lee S, Satish S, Chen AJX, Liu A, Enkhtsetseg N, Mateen FJ, Guinea Epilepsy Project. Cognitive Status in People With Epilepsy in the Republic of Guinea: A Prospective, Case-Control Study. Ann Clin Transl Neurol. 2026 May; 13(5): 994-1004. https://doi.org/10.1002/acn3.70282 PMID: 41400255
- Udawatta M, Mateen FJ. Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis. Ann Clin Transl Neurol. 2026 Apr; 13(4): 850-859. https://doi.org/10.1002/acn3.70302. PMID: 41475891.
- Mastick ML, Enkhtsetseg N, Sadok J, Mochetti M, Sorby Adams A, Guo J, Hacker CT, Hjerthen IG, Lee S, Satish S, Ham AS, Hill J, Balaban D, Kyle K, Gillani RL, Matiello M, Videnovic A, Klawiter EC, Kimberly WT, Mateen FJ. Feasibility and Tolerability of Performing Portable MRI for Neurological Disorders in an Outpatient Neurology Clinic: A Prospective Cohort. Ann Clin Transl Neurol. 2026 Jan. https://doi.org/10.1002/acn3.70326 PMID: 41607060
- Hill JB, Mastick ML, Chiong-Rivero H, Grebenciucova E, Mateen FJ. Characterizing financial toxicity among people living with neuromyelitis optica spectrum disorder. Mult Scler. 2025 Oct; 31(11): 1370-1380. https://doi.org/10.1177/13524585251365139 PMID: 40922643
- Satish S, Patel A, Mastick ML, Lee S, Hotan GC, Ham AS, Mateen FJ. Multiple Sclerosis in the Emergency Department: A Retrospective Case-Control Study in a Large U.S. Center. Neurol Neuroimmunol Neuroinflamm. 2025 Sep; 12(5): e200445-. https://doi.org/10.1212/NXI.0000000000200445 PMID: 40674662
- Rezaei SJ, Cissé FA, Touré ML, Duan R, Rice DR, Ham AS, de Walque D, Mateen FJ. E = mc2: Education (E), medication (m), and conditional cash (c2) to improve uptake of antiseizure medications in a low-resource population: Protocol for randomized trial. Epilepsia Open. 2024 Feb; 9(1): 445-454. https://doi.org/10.1002/epi4.12889 PMID: 38131270
- Rice DR, Guelngar CO, Traoré M, Condé ML, Diallo D, Lee NJ, Ham AS, Cissé FA, Mateen FJ, Guinea Epilepsy Project. Impact of a free medication intervention on seizure recurrence and anxious and depressive symptoms in people living with epilepsy in the Republic of Guinea. Trop Med Int Health. 2024 Jan; 29(1): 33- https://doi.org/10.1111/tmi.13950 PMID: 38031206